BioCentury | Jul 20, 2015
Emerging Company Profile

Shot in the DYRK

...help screen for quiescence targets and molecules. Companies and Institutions Mentioned Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc....
...al. "Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells." Molecular Cancer Therapeutics (2011) Sidebars Felicitex Therapeutics Inc....
BioCentury | Jun 22, 2015
Company News

Diaxonhit, Felicitex Therapeutics deal

...annual licensing payments. The companies did not disclose additional financial details. Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc....
BioCentury | Dec 15, 2014
Company News

Selvita, Felicitex Therapeutics deal

...undisclosed development, regulatory and commercial milestones, plus low single-digit royalties. Selvita S.A. (Warsaw:SLV), Krakow, Poland Felicitex Therapeutics Inc....
Items per page:
1 - 3 of 3
BioCentury | Jul 20, 2015
Emerging Company Profile

Shot in the DYRK

...help screen for quiescence targets and molecules. Companies and Institutions Mentioned Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc....
...al. "Inactivation of Mirk/Dyrk1b kinase targets quiescent pancreatic cancer cells." Molecular Cancer Therapeutics (2011) Sidebars Felicitex Therapeutics Inc....
BioCentury | Jun 22, 2015
Company News

Diaxonhit, Felicitex Therapeutics deal

...annual licensing payments. The companies did not disclose additional financial details. Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc....
BioCentury | Dec 15, 2014
Company News

Selvita, Felicitex Therapeutics deal

...undisclosed development, regulatory and commercial milestones, plus low single-digit royalties. Selvita S.A. (Warsaw:SLV), Krakow, Poland Felicitex Therapeutics Inc....
Items per page:
1 - 3 of 3